SCHEMBL21201116

SCHEMBL21201116

Cn1cnnc1C(F)(F)C1(c2cccc(NC(=O)O)c2)CC1

nearest known ligand 0.44

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ CBLB Q13191 16/20 0.44
▸ POLB P06746 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ LMNA P02545 1/20 0.39
▸ GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29866714 0.87 HCRTR1 (0.44) CBLB
SCHEMBL21200852 0.82 CBLB (0.70) CBLB
SCHEMBL29866670 0.82 CBLB (0.70) CBLB
SCHEMBL21200967 0.82 MEN1 (0.35) CBLBPOLB
SCHEMBL21200478 0.79 CBLB (0.37) CBLB
SCHEMBL29867316 0.79 CBLB (0.37) CBLB
SCHEMBL21200198 0.76 CBLB (0.66) CBLBPOLBMAPT
SCHEMBL29841650 0.75 CBLB (0.37) CBLB
SCHEMBL21201152 0.75 CBLB (0.55) CBLBPOLBMAPTLMNAGAA
SCHEMBL21201167 0.74 CBLB (0.69) CBLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3743063-A1 INHIBITORS OF CBL-B AND METHODS OF USE THEREOF Nurix Therapeutics, Inc. (US) 2020-12-02 — — EP disclosed
WO-2019148005-A1 INHIBITORS OF CBL-B AND METHODS OF USE THEREOF NURIX THERAPEUTICS, INC. (US) 2019-08-01 — — WO disclosed
Send feedback